• / Free eNewsletters & Magazine
  • / My Account
Home>Insiders>Thomas S. Price, Jr.

Thomas S. Price, Jr.

  1. All
  2. 3rd Party
  3. Investing
  1. UPDATE: Obama's economic legacy: Here's where we (and these 4 industries) are better off

    UPDATE: Obama's economic legacy: Here's where we (and these 4 industries) are better off

  2. UPDATE: Obama's economic legacy: Here's where we (and these 4 industries) are better off

    UPDATE: Obama's economic legacy: Here's where we (and these 4 industries) are better off

  3. UPDATE: Zocdoc CEO Oliver Kharraz on why 2017's health-care uncertainty is a good thing

    UPDATE: Zocdoc CEO Oliver Kharraz on why 2017's health-care uncertainty is a good thing

  4. UPDATE: Zocdoc CEO Oliver Kharraz on why 2017's health-care uncertainty is a good thing

    UPDATE: Zocdoc CEO Oliver Kharraz on why 2017's health-care uncertainty is a good thing

  5. Republican Congress Promises to Move Quickly Toward Goals -- 2nd Update

    Republican Congress Promises to Move Quickly Toward Goals -- 2nd Update

  6. Republican Congress Promises to Move Quickly Toward Goals -- Update

    Republican Congress Promises to Move Quickly Toward Goals -- Update

  7. Republican Congress Promises to Move Quickly Toward Goals -- 3rd Update

    Republican Congress Promises to Move Quickly Toward Goals -- 3rd Update

  8. Republican Congress Promises to Move Quickly Toward Goals

    Republican Congress Promises to Move Quickly Toward Goals

  9. UPDATE: Innocoll stock slides 65% after FDA setback for pain treatment

    UPDATE: Innocoll stock slides 65% after FDA setback for pain treatment

  10. UPDATE: Innocoll stock slides 65% after FDA setback for pain treatment

    UPDATE: Innocoll stock slides 65% after FDA setback for pain treatment

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.